Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma
スポンサーリンク
概要
- 論文の詳細を見る
- 2008-02-01
著者
-
PARISE Robert
Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, Room G27e,
-
COVEY Joseph
Toxicology and Pharmacology Branch, Developmental Therapeutics Program, National Cancer Institute
-
EGORIN Merrill
Molecular Therapeutics/Drug Discovery Program, University of Pittsburgh Cancer Institute, Room G27e,
-
Covey Joseph
Toxicology And Pharmacology Branch Developmental Therapeutics Program Division Of Cancer Treatment A
-
BEUMER Jan
Molecular Therapeutics/Drug Discovery Program, University
-
KANGANI Cyrous
Division of Endocrinology and Metabolism, Department of Medicine, University of Pittsburgh School of
-
HOLLERAN Julianne
Molecular Therapeutics/Drug Discovery Program, University
-
EISEMAN Julie
Molecular Therapeutics/Drug Discovery Program, University
-
SMITH Nicola
Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment
-
PERRINE Susan
Cancer Research Center, Boston University School of Medicine
-
Parise Robert
Molecular Therapeutics/drug Discovery Program University
-
Egorin Merrill
Molecular Therapeutics/drug Discovery Program University
-
Beumer Jan
Molecular Therapeutics/drug Discovery Program University
-
Smith Nicola
Toxicology And Pharmacology Branch Developmental Therapeutics Program Division Of Cancer Treatment A
-
Perrine Susan
Cancer Research Center Boston University School Of Medicine
-
Eiseman Julie
Molecular Therapeutics/drug Discovery Program University
-
Parise Robert
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
-
Kangani Cyrous
Division Of Endocrinology And Metabolism Department Of Medicine University Of Pittsburgh School Of M
-
Egorin Merrill
Molecular Therapeutics/drug Discovery Program University Of Pittsburgh Cancer Institute
-
Parise Robert
Department Of Pharmaceutical Sciences University Of Pittsburgh School Of Pharmacy
-
Holleran Julianne
Molecular Therapeutics/drug Discovery Program University
-
Covey Joseph
Toxicology And Pharmacology Branch Developmental Therapeutics Program Division Of Cancer Treatment A
関連論文
- Liquid chromatography-electrospray tandem mass spectrometric assay suitable for quantitation of halofuginone in plasma
- Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma
- Quantitative determination of zebularine (NSC 309132), a DNA methyltransferase inhibitor, and three metabolites in murine plasma by high-performance liquid chromatography coupled with on-line radioactivity detection
- Sensitive liquid chromatography-mass spectrometry assay for quantitation of docetaxel and paclitaxel in human plasma
- A liquid chromatography-electrospray ionization tandem mass spectrometric assay for quantitation of the histone deacetylase inhibitor, vorinostat (suberoylanilide hydroxamicacid, SAHA), and its metabolites in human serum
- Liquid chromatographic-mass spectrometric assay for quantitation of imatinib and its main metabolite (CGP 74588) in plasma
- New method for GC/FID and GC-C-IRMS analysis of plasma free fatty acid concentration and isotopic enrichment
- A high-performance liquid chromatography-mass spectrometry assay for quantitation of the tyrosine kinase inhibitor nilotinib in human plasma and serum
- Liquid chromatography-mass spectrometric assay for the quantitation in human plasma of ABT-888, an orally available, small molecule inhibitor of poly(ADP-ribose) polymerase